Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/97764

In Collections

This item can be found in the following collections:

Willemze, R.; Muus, P.; Halkes, S.J.M.; Meloni, G.; Suciu, S.; Meert, L.; ... ; Marie, J.P. (2011)

Clofarabine in Combination with a Standard Remission Induction Regimen (AraC and idarubicin) in Patients with Previously Untreated Intermediate and Bad Risk Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS): Phase I Results of An Ongoing Phase I/II Study of the EORTC-LG and GIMEMA(EORTC GIMEMA 06061/AML-14A trial)

Article / Letter to editor
All authors
Willemze, R.; Muus, P.; Halkes, S.J.M.; Meloni, G.; Suciu, S.; Meert, L.; Flament, J.; Karrasch, M.; Vignetti, M.; Amadori, S.; Witte, T.M. de; Marie, J.P.
Date
2011-11-18
Journal
Blood
Volume
118
Issue
21
Pages
1120 - 1121